The BRCA1/2 genes are well-studied tumour suppressors, and mutations in these genes have been shown to promote oncogenesis for breast cancer in particular, but have also been associated with ovarian cancer and to a lesser extent prostate and endometrial cancers (Werner, 2022). The gene discussed is BRCA1; the disease is breast carcinoma.